Neurol. praxi. 2010;11(5):297-299

Pregnancy and multiple sclerosis

MUDr.Eva Meluzínová
Centrum pro demyelinizační onemocnění, Neurologická klinika UK 2. LF a FN Motol, Praha

Multiple sclerosis is a chronic autoimmune disease that is more common in women and typically has its onset during the childbearing

years. That brings to the forefront the issue of pregnancy during the course of this disease. As late as the second half of the twentieth

century, women with multiple sclerosis were forbidden to become pregnant because of frequent attacks after the delivery and concerns

for subsequent maternal disability. Owing to planned pregnancy and modern therapeutic approaches, the disease can be stabilized

even in the period of a major risk, such as the immediate postpartum period and the following six months. Under these circumstances,

most women with this disease can become pregnant at present; however, ideally during the stable period of the disease.

Keywords: multiple sclerosis, relapse, corticoids, pregnancy, labour, intravenous immunoglobulins, breastfeeding

Published: December 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Meluzínová E. Pregnancy and multiple sclerosis. Neurol. praxi. 2010;11(5):297-299.
Download citation

References

  1. Achiron A, Kishner I, Dolev M, Stern Y, Dulitzky M, Schiff E, Achiron R. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol. 2004; 251(9): 1133-1137. Go to original source... Go to PubMed...
  2. Alonso A, Clark CJ. Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence. J Neurol Sci. 2009; 286(1-2): 73-75. Go to original source... Go to PubMed...
  3. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007; 197(6): 585. e1-7; discussion 683-684, e1-7. Go to original source... Go to PubMed...
  4. Ferrero S, Pretta S, Ragni N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2004; 115(1): 3-9. Go to original source... Go to PubMed...
  5. Gregg C. Pregnancy, prolactin and white matter regeneration. J Neurol Sci. 2009; 285(1-2): 22-27. Go to original source... Go to PubMed...
  6. Haas J. High dose IVIG in the post partum period for prevention of exacerbations in MS. Mult Scler. 2000; 6 Suppl 2: 18-20; discussion S33. Go to original source...
  7. Hartung HP. Advances in the understanding of the mechanism of action of IVIg. J Neurol. 2008; 255(Suppl 3): 3-6. Go to original source... Go to PubMed...
  8. Langer-Gould A, Huang SM, Gupta R, Leimpeter AD, Greenwood E, Albers KB, Van Den Eeden SK, Nelson LM. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol. 2009; 66(8): 958-963. Go to original source... Go to PubMed...
  9. Lee M, O'Brien P. Pregnancy and multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 2008; 79: 1308-1311. Go to original source... Go to PubMed...
  10. Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, Chang P, Francis GS. Pregnancy outcomes during treatment with interferon beta1a in patients with multiple sclerosis. Neurology. 2005; 65(6): 802-806. Go to original source... Go to PubMed...
  11. Seze J, Chapelotte M, Delalande S, Ferriby D, Stojkovic T, Vermersch P. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler. 2004; 10(5): 596-597. Go to original source... Go to PubMed...
  12. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol. 2002; 52(4): 421-428. Go to original source... Go to PubMed...
  13. Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol. 2003; 171(11): 6267-6274. Go to original source... Go to PubMed...
  14. Sorensen PS. The role of intravenous immunoglobulin in the treatment of multiple sclerosis. J Neurol Sci. 2003; 206(2): 123-130. Go to original source... Go to PubMed...
  15. Vukusic S, Hutchinson M, Hours M, Moreau T, CortinovisTourniaire P, Adeleine P, Confavreux C. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of postpartum relapse. Brain. 2004; 127(Pt 6): 1353-1360. Go to original source... Go to PubMed...
  16. Weber-Schoendorfer C, Schaefer C. Multiple sclerosis, immunomodulators and pregnancy outcome: a prospective observational study. Mult Scler. 2009; 15(9): 1037-1042. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.